In a study evaluating IGF1 and IGFBP3 levels in 40 cirrhotic patients, 63 HCC patients and 150 healthy subjects, both serum IGF1 and IGFBP3 levels were significantly lower in cirrhotic and HCC patients than in controls. Here, IGFBP3 is linked to hepatocellular carcinoma.